Timothy Lu - Sep 14, 2021 Form 4 Insider Report for DICE Therapeutics, Inc. (DICE)

Role
CMO
Signature
/s/ Scott Robertson as attorney-in-fact for Timothy Lu
Stock symbol
DICE
Transactions as of
Sep 14, 2021
Transactions value $
$0
Form type
4
Date filed
9/16/2021, 09:24 PM
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding DICE Common Stock 162K Sep 14, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (right to buy) Award $0 +31.3K $0.00 31.3K Sep 14, 2021 Common Stock 31.3K $17.00 Direct F3
transaction DICE Stock Option (right to buy) Award $0 +25.6K $0.00 25.6K Sep 14, 2021 Common Stock 25.6K $17.00 Direct F4
transaction DICE Stock Option (right to buy) Award $0 +25.8K $0.00 25.8K Sep 14, 2021 Common Stock 25.8K $17.00 Direct F5
transaction DICE Stock Option (right to buy) Award $0 +17.4K $0.00 17.4K Sep 14, 2021 Common Stock 17.4K $17.00 Direct F5

Explanation of Responses:

Id Content
F1 The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
F2 Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
F3 The option vests as to 1/4 of the total shares on August 24, 2020, and then 1/48th of the total shares vest monthly, subject to the Reporting Holder's continuing employment with the Registrant.
F4 The option vests as to 1/48th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
F5 The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continuing employment with the Registrant.